Overview
Cartalax (scientifically identified by the amino acid sequence Ala-Glu-Asp) is a high-purity synthetic tripeptide. In the landscape of advanced musculoskeletal research and regenerative medicine, Cartalax is classified as a tissue-specific bioregulator designed to act specifically on connective tissue cells, particularly chondrocytes (cartilage cells). Its primary research focus involves the normalization of metabolic processes within the cartilaginous matrix and the modulation of protein synthesis necessary for structural integrity. Cartalax provides researchers with a high-precision experimental tool to investigate the mitigation of degenerative joint changes, the promotion of collagen synthesis, and the restoration of systemic functional mobility in aged or experimental injury models.
Our Cartalax is synthesized in an ISO 9001:2015 certified environment utilizing high-precision Solid-Phase Peptide Synthesis (SPPS). We achieve an ultra-high chemical purity of ≥99%, verified by HPLC and Mass Spectrometry (MS). This rigorous production standard ensures the tripeptide is free from truncated sequences and residual chemical reagents, guaranteeing the consistency and structural fidelity required for long-term orthopaedic assays and cellular repair studies.
Research Applications & Mechanisms
Chondrocyte Metabolism & Matrix Repair
Investigating the upregulation of cellular activity within cartilage tissue to study the peptide’s role in promoting the synthesis of glycosaminoglycans and proteoglycans.
Connective Tissue Regeneration
Researching the mechanisms through which short-chain bioregulators accelerate the repair of tendons, ligaments, and spinal discs in research designs.
Modulation of Osteoarthritis Signaling
Studying the influence of Cartalax on reducing inflammatory markers within the joint capsule and its role in investigating the slowing of degenerative joint decline.
DNA-Peptide Interaction & Gene Expression
Exploring the impact of the Ala-Glu-Asp sequence on the epigenetic regulation of connective tissue cells to research the restoration of healthy tissue function.
Technical Specifications
| Parameter | Laboratory Standard |
| Compound | Cartalax |
| Sequence | L-Ala-L-Glu-L-Asp |
| Purity (HPLC) | ≥99% (Pharmaceutical Grade) |
| Physical Appearance | Fine, Smooth & Flat Lyophilized Cake |
| Molecular Weight | 333.3 g/mol |
| Concentration | Available in 20mg vials |
| Solubility | Highly Soluble in Water (Aqueous) / PBS |
| Batch Control | MS & HPLC Analysis Verified |
Key Features & Quality Assurance
Pharmaceutical-Grade Lyophilization
Our proprietary vacuum-sealing process ensures the Cartalax powder surface is perfectly smooth, flat, and delicate. This uniform “cake” structure ensures rapid, clear reconstitution and maintains the molecular stability of the tripeptide during long-term storage.
High-Fidelity Sequence Integrity
Every batch undergoes strict Mass Spectrometry (MS) to confirm the exact amino acid sequence (Ala-Glu-Asp), ensuring maximal target specificity and reproducible results in complex musculoskeletal signaling research.
Reconstitution & Storage
Reconstitution Guide
-
Preparation: Allow the vial to reach room temperature. Centrifuge for 30-60 seconds to ensure the Cartalax cake is at the base.
-
Solvent: Reconstitute with Sterile Water or PBS.
-
Technique: Gently introduce the diluent against the vial wall. DO NOT SHAKE; swirl gently until the solution is clear and transparent.
Storage Protocols
-
Long-term: Store at -20°C (Maintains potency for up to 24 months).
-
Short-term: Stable at 2–8°C for up to 3 months.
-
Post-Reconstitution: Store at 2–8°C and utilize within 14-21 days for optimal results.
Shipping & Documentation
-
Global Logistics: Shipped in discreet, temperature-controlled packaging to maintain the structural integrity of the Cartalax peptide.
-
Verified Quality: A batch-specific COA and HPLC/MS reports are available for every order.
-
Reshipment Policy: We provide a guaranteed reshipment policy for any lost or customs-intercepted orders (terms apply).
⚠️ Research Disclaimer
Product-Specific Safety Notice: This Cartalax is strictly for laboratory research and analytical purposes. It is NOT intended for human or veterinary administration. All research must be conducted by qualified professionals.
Scientific Resources & References
-
National Center for Biotechnology Information (NCBI): Bioregulatory Peptides and Connective Tissue Research
-
ScienceDirect (Elsevier): Peer-reviewed Research on Short Peptides and Chondrocyte Regeneration
🔍 Deep Dive Research
-
[Technical Guide]: How to Reconstitute and Store Lyophilized Peptides for Maximum Potency
-
[Joint Health Study]: Rebuilding the Foundation: The Science of Cartalax in Modern Orthopaedic Research
sahmihakim –
Delivery was on time.